StockMacro
Company, fund or insider

Help

Menu

Moleculin Biotech

$7.74 -84% in 6 monthsMarket cap $8.2M

MBRX on XNAS, Health Care, Moleculin Biotech, Inc., job postings

Measures activity, not value. Not investment advice.

Stock fell 96% in a year and drew a delisting notice, though it rose 23% in the last month.

  • BadCash of $7.3M against a net loss of $11.4M

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

Moleculin Biotech Inc is a late-stage pharmaceutical development company currently evaluating Annamycin, also known as L-Annamycin and by its generic name naxtarubicin. The company has two additional portfolios of technologies for hard-to-treat cancers and viruses with clinical and preclinical research funded by investigators at academic institutions. The Company operates in one reportable segment, which is the development and commercialization of drug products.

Industry
Pharmaceutical preparations (Health Care)
Employees
17
Website
moleculin.com
Listed
Nasdaq, US
Last results
16 Nov 2026
Next results
expected around 18 Mar 2027 (an estimate: a year ago it reported on 19 Mar 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $0, net loss $6.5M.
Quarter to 31 Dec 2021: revenue $0, net income -$2.8MQuarter to 31 Dec 2021: revenue $0, net income -$2.8MQuarter to 31 Mar 2022: revenue $0, net income -$6.9MQuarter to 31 Mar 2022: revenue $0, net income -$6.9MQuarter to 30 Jun 2022: revenue $0, net income -$6.8MQuarter to 30 Jun 2022: revenue $0, net income -$6.8MQuarter to 30 Sep 2022: revenue $0, net income -$8.6MQuarter to 30 Sep 2022: revenue $0, net income -$8.6MQuarter to 31 Dec 2022: revenue $0, net income -$6.8MQuarter to 31 Dec 2022: revenue $0, net income -$6.8MQuarter to 31 Mar 2023: revenue $0, net income -$7.9MQuarter to 31 Mar 2023: revenue $0, net income -$7.9MQuarter to 30 Jun 2023: revenue $0, net income -$6.0MQuarter to 30 Jun 2023: revenue $0, net income -$6.0MQuarter to 30 Sep 2023: revenue $0, net income -$5.6MQuarter to 30 Sep 2023: revenue $0, net income -$5.6MQuarter to 31 Dec 2023: revenue $0, net income -$10.3MQuarter to 31 Dec 2023: revenue $0, net income -$10.3MQuarter to 31 Mar 2024: revenue $0, net income -$5.0MQuarter to 31 Mar 2024: revenue $0, net income -$5.0MQuarter to 30 Jun 2024: revenue $0, net income -$4.3MQuarter to 30 Jun 2024: revenue $0, net income -$4.3MQuarter to 30 Sep 2024: revenue $0, net income -$10.6MQuarter to 30 Sep 2024: revenue $0, net income -$10.6MQuarter to 31 Dec 2024: revenue $0, net income -$1.9MQuarter to 31 Dec 2024: revenue $0, net income -$1.9MQuarter to 31 Mar 2025: revenue $0, net income -$6.4MQuarter to 31 Mar 2025: revenue $0, net income -$6.4MQuarter to 30 Jun 2025: revenue $0, net income -$7.6MQuarter to 30 Jun 2025: revenue $0, net income -$7.6MQuarter to 30 Sep 2025: revenue $0, net income -$25.4MQuarter to 30 Sep 2025: revenue $0, net income -$25.4MQuarter to 31 Dec 2025: revenue $0, net income –Quarter to 31 Mar 2026: revenue $0, net income -$12.8MQuarter to 31 Mar 2026: revenue $0, net income -$12.8MQuarter to 30 Jun 2026: revenue $0, net income -$7.6MQuarter to 30 Jun 2026: revenue $0, net income -$7.6MQuarter to 30 Sep 2026: revenue $0, net income -$6.5MQuarter to 30 Sep 2026: revenue $0, net income -$6.5M
31 Dec 2021RevenueNet incomeNet losstallest bar $25.4M30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026$0-$6.5M
30 Jun 2026$0-$7.6M
31 Mar 2026$0-$12.8M
31 Dec 2025$0–
30 Sep 2025$0-$25.4M
30 Jun 2025$0-$7.6M
31 Mar 2025$0-$6.4M
31 Dec 2024$0-$1.9M
30 Sep 2024$0-$10.6M
30 Jun 2024$0-$4.3M
31 Mar 2024$0-$5.0M
31 Dec 2023$0-$10.3M
30 Sep 2023$0-$5.6M
30 Jun 2023$0-$6.0M
31 Mar 2023$0-$7.9M
31 Dec 2022$0-$6.8M
30 Sep 2022$0-$8.6M
30 Jun 2022$0-$6.8M
31 Mar 2022$0-$6.9M
31 Dec 2021$0-$2.8M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. – –
Revenue growthRevenue of the last 12 months compared with the 12 months before. – +11%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. -$11.4M -$51.0M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). – –
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. – – 73.2%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. – – -25.0%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. – – -18.2%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. – -58.8%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. – -$22.5M
CashCash, cash equivalents and short-term investments on the latest balance sheet. $7.3M $6.7M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $0 $0
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). -$7.3M (net cash) -$6.7M
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. 0.0 0.0
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $13.65
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. loss 19.3
P/SPrice to sales: market cap divided by revenue of the last 12 months. – 5.0
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. – 5.0
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 0.57 2.0

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
Moleculin BiotechMBRX (this company) $8.2Mloss–––
Palatin TechnologiesPTN $8.2Mloss1.7-47%-385%
VyomeHIND $8.4Mloss–––
Dare BioscienceDARE $8.0Mloss5.7–-750%
Cellectar Biosciences INC NEWCLRB $8.0Mloss–––
Lexaria BioscienceLEXX $8.5Mloss–-69%–

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

55%

589K shares held by 13F filers (30 Sep 2026) of 1.1M outstanding (6 Nov 2026)

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

5.1%

55K shares sold short (30 Oct 2026) of 1.1M outstanding (6 Nov 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

1.0

55K shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

-57%

126K shares sold short in the report before, 55K on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

65%

65% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 49%

News Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

17

17 articles in the last 7 days; its usual week has 1.5 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

11×

17 articles in the last 7 days; its usual week has 1.5.

Price $7.74 on 20 Nov 2026, -96% over 12 months (12-month range $5.30 to $213.60)

  • Sharp change
  • 8-K and other filings
Insider net buying (open market). Insiders bought a net $0 in the last 12 months (the 12 months before: $350K).
Revenue per quarter. Revenue $0 in the latest quarter.
Capital spending per quarter. Capital spending $0 in the latest quarter.
Institutional holders (13F filers). 22 13F filers reported holding it in the latest 13F quarter, -12% on a year earlier.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: h-1b/e-3 applications certified, federal obligations, lobbying spend, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
9 Oct 20268-K and other filingsDirector or officer change
9 Oct 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
18 Sep 20268-K and other filingsDelisting notice or listing transfer
30 Jul 20268-K and other filingsRegistered new securities for sale (S-1)
30 Jul 20268-K and other filingsRegistered new securities for sale (S-1)
29 Jul 20268-K and other filingsRegistered new securities for sale (S-1)
21 Nov 20258-K and other filingsDelisting notice or listing transfer
18 Nov 2025Sharp changeShort interest spike: short interest spike, 8.7M vs usual 853K (2025-10-31); 71.2x the same period a year earlier
28 Oct 2025Sharp changeShort interest spike: short interest spike, 3.9M vs usual 664K (2025-10-15); 22.8x the same period a year earlier
16 Sep 2025Sharp changeShort interest spike: short interest spike, 2.8M vs usual 464K (2025-08-29); 25.8x the same period a year earlier
2 Sep 2025Sharp changeShort interest spike: short interest spike, 3.3M vs usual 318K (2025-08-15); 64.2x the same period a year earlier
12 Aug 2025Sharp changeShort interest spike: short interest spike, 4.1M vs usual 172K (2025-07-31); 145.4x the same period a year earlier
29 Jul 2025Sharp changeShort interest spike: short interest spike, 5.2M vs usual 171K (2025-07-15); 244.9x the same period a year earlier
1 Jul 2025Sharp changeShort interest spike: short interest spike, 1.9M vs usual 148K (2025-06-13); 84.5x the same period a year earlier
27 Jun 20258-K and other filingsDelisting notice or listing transfer
16 Jun 20258-K and other filingsRegistered new securities for sale (S-1)
11 Jun 20258-K and other filingsRegistered new securities for sale (S-1)
6 Jun 20258-K and other filingsRegistered new securities for sale (S-1)
3 Jun 2025Sharp changeShort interest spike: short interest spike, 982K vs usual 115K (2025-05-15); 28.7x the same period a year earlier
2 Jun 20258-K and other filingsRegistered new securities for sale (S-1)
23 May 20258-K and other filingsDelisting notice or listing transfer
13 May 2025Sharp changeShort interest spike: short interest spike, 725K vs usual 95K (2025-04-30); 23.3x the same period a year earlier
15 Apr 2025Sharp changeShort interest spike: short interest spike, 572K vs usual 53K (2025-03-31); 12.7x the same period a year earlier
31 Mar 20258-K and other filingsRegistered new securities for sale (S-1)
18 Mar 2025Sharp changeShort interest spike: short interest spike, 1.1M vs usual 48K (2025-02-28); 8.0x the same period a year earlier
4 Mar 2025Sharp changeShort interest spike: short interest spike, 2.2M vs usual 48K (2025-02-14); 16.0x the same period a year earlier
11 Feb 20258-K and other filingsRegistered new securities for sale (S-1)
10 Feb 20258-K and other filingsRegistered new securities for sale (S-1)
29 Jan 20258-K and other filingsRegistered new securities for sale (S-1)
13 Dec 20248-K and other filingsRegistered new securities for sale (S-1)
25 Oct 20248-K and other filingsDirector or officer change
25 Oct 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
15 Aug 20248-K and other filingsRegistered new securities for sale (S-1)
15 Aug 20248-K and other filingsRegistered new securities for sale (S-1)
30 Jul 20248-K and other filingsRegistered new securities for sale (S-1)
22 Jul 20248-K and other filingsRegistered new securities for sale (S-1)
2 Feb 20248-K and other filingsRegistered new securities for sale (S-1)
5 Jan 20248-K and other filingsDirector or officer change
5 Jan 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
28 Dec 2023Sharp changeClustered insider buying: clustered insider buying (3 independent filers, 3 filing(s) in 30 days, value_usd total 160K)
3 Nov 20238-K and other filingsDelisting notice or listing transfer
5 May 20238-K and other filingsDelisting notice or listing transfer
3 Feb 20238-K and other filingsA major agreement ended
1 Mar 20228-K and other filingsDirector or officer change
1 Mar 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
Insider net buying (open market)
Month from 1 Nov 2022: $191K published
Month from 1 Dec 2023: $160K published
Month from 1 Jun 2025: $350K published
Month from 1 Aug 2026: $0 published
Revenue per quarter
Quarter ended 31 Dec 2021: $0; public on 25 Mar 2022
Quarter ended 31 Mar 2022: $0; public on 12 May 2022
Quarter ended 30 Jun 2022: $0; public on 13 Aug 2022
Quarter ended 30 Sep 2022: $0; public on 11 Nov 2022
Quarter ended 31 Dec 2022: $0; public on 23 Mar 2023
Quarter ended 31 Mar 2023: $0; public on 11 May 2023
Quarter ended 30 Jun 2023: $0; public on 11 Aug 2023
Quarter ended 30 Sep 2023: $0; public on 14 Nov 2023
Quarter ended 31 Dec 2023: $0; public on 23 Mar 2024
Quarter ended 31 Mar 2024: $0; public on 11 May 2024
Quarter ended 30 Jun 2024: $0; public on 14 Aug 2024
Quarter ended 30 Sep 2024: $0; public on 9 Nov 2024
Quarter ended 31 Dec 2024: $0; public on 22 Mar 2025
Quarter ended 31 Mar 2025: $0; public on 14 May 2025
Quarter ended 30 Jun 2025: $0; public on 13 Aug 2025
Quarter ended 30 Sep 2025: $0; public on 14 Nov 2025
Quarter ended 31 Dec 2025: $0; public on 19 Mar 2026
Quarter ended 31 Mar 2026: $0; public on 15 May 2026
Quarter ended 30 Jun 2026: $0; public on 14 Aug 2026
Quarter ended 30 Sep 2026: $0; public on 14 Nov 2026
Capital spending per quarter
Quarter ended 31 Dec 2021: $19K, +19% on a year earlier; public on 25 Mar 2022
Quarter ended 31 Mar 2022: $6K; public on 12 May 2022
Quarter ended 30 Jun 2022: $61K; public on 13 Aug 2022
Quarter ended 31 Mar 2023: $0, -100% on a year earlier; public on 11 May 2023
Quarter ended 30 Jun 2023: $15K, -75% on a year earlier; public on 11 Aug 2023
Quarter ended 30 Sep 2023: $28K; public on 14 Nov 2023
Quarter ended 31 Dec 2023: $81K; public on 23 Mar 2024
Quarter ended 31 Mar 2024: $0; public on 14 May 2025
Quarter ended 30 Jun 2024: $13K, -13% on a year earlier; public on 14 Aug 2024
Quarter ended 30 Sep 2024: $0, -100% on a year earlier; public on 9 Nov 2024
Quarter ended 31 Dec 2024: $0, -100% on a year earlier; public on 22 Mar 2025
Quarter ended 31 Mar 2025: $0; public on 14 May 2025
Quarter ended 30 Jun 2025: $0, -100% on a year earlier; public on 13 Aug 2025
Quarter ended 30 Sep 2025: $0; public on 14 Nov 2025
Quarter ended 31 Dec 2025: $0; public on 19 Mar 2026
Institutional holders (13F filers)
31 Dec 2021 report: 23; public on 14 Feb 2022
31 Mar 2022 report: 21; public on 16 May 2022
30 Jun 2022 report: 24; public on 15 Aug 2022
30 Sep 2022 report: 22; public on 14 Nov 2022
31 Dec 2022 report: 22; public on 14 Feb 2023
31 Mar 2023 report: 22; public on 15 May 2023
30 Jun 2023 report: 21; public on 14 Aug 2023
30 Sep 2023 report: 21; public on 14 Nov 2023
31 Dec 2023 report: 24; public on 14 Feb 2024
31 Mar 2024 report: 19; public on 15 May 2024
30 Jun 2024 report: 15; public on 14 Aug 2024
30 Sep 2024 report: 18; public on 14 Nov 2024
31 Dec 2024 report: 20; public on 14 Feb 2025
31 Mar 2025 report: 23; public on 15 May 2025
30 Jun 2025 report: 20; public on 14 Aug 2025
30 Sep 2025 report: 25; public on 14 Nov 2025
31 Dec 2025 report: 17; public on 17 Feb 2026
31 Mar 2026 report: 20; public on 15 May 2026
30 Jun 2026 report: 18; public on 14 Aug 2026
30 Sep 2026 report: 22; public on 16 Nov 2026

What is unusual now

  • Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is short sale volume on FINRA-reported off-exchange venues (TRFs + ADF), shares per day at 15K (20 Nov 2026), 3.3× its normal reading; higher than 28% of its own history.
  • Insider net buying (open market): Insiders bought a net $0 in the last 12 months (the 12 months before: $350K).
  • Revenue per quarter: Revenue $0 in the latest quarter.
  • Capital spending per quarter: Capital spending $0 in the latest quarter.

Latest records

The names and amounts behind the totals, newest first

Insider trades

All 17 insider trades

No trades in the last 90 days; the latest was filed 5 Aug 2026. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
5 Aug 2026Donald H PickerChief Science OfficerBuy173,333Not filedNot filedForm 4
5 Aug 2026Jonathan P. FosterChief Financial OfficerBuy293,333Not filedNot filedForm 4
5 Aug 2026Walter Klemp VCEO and PresidentBuy533,333Not filedNot filedForm 4
23 Jun 2025Walter Klemp VCEO and PresidentBuy675,675$0.37$250KForm 4
23 Jun 2025Jonathan P. FosterChief Financial OfficerBuy270,270$0.37$100KForm 4
27 Dec 2023Robert E. GeorgeDirectorBuy14,493$0.69$10KForm 4
27 Dec 2023Walter Klemp VCEO and PresidentBuy188,404$0.69$130KForm 4
27 Dec 2023Jonathan P. FosterChief Financial OfficerBuy28,986$0.69$20KForm 4

22 institutions reported shares at the end of Q3 2026, 55% of the shares outstanding; 7 opened a position, 2 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
Jane Street Group, LLC142K13.4%$71KNew+142K
Vanguard Fiduciary Trust Co108K10.2%$54K+78K+262%
Geode Capital Management, LLC105K9.86%$52K+57K+122%
XTX Topco Ltd61K5.73%$30K+38K+165%
HRT Financial LP60K5.67%New+60K
Big Sioux Wealth Management43K4.04%$21K+23K+113%
Vanguard Capital Management LLC42K3.98%$21KNo change
Stratos Wealth Partners, LTD.38K3.54%$19KNew+38K
Rockefeller Capital Management L.P.15K1.41%$8KNo change
Susquehanna International Group, LLP15K1.37%$7KNew+15K

Company events

All 93 company events

In 12 months: 4 major agreements, 3 share registrations, 1 delisting notice, 1 director or officer change. Results releases and routine reports are left out.

FiledWhat happenedSource
9 Oct 2026Director or officer changeSame filing: shareholder vote results8-K
18 Sep 2026Delisting notice or listing transfer8-K
3 Aug 2026Signed a major agreement8-K
30 Jul 2026Registered new securities for sale (S-1)S-1/A
30 Jul 2026Registered new securities for sale (S-1)S-1/A
29 Jul 2026Registered new securities for sale (S-1)S-1
20 Feb 2026Signed a major agreementSame filing: sold shares privately8-K
22 Dec 2025Signed a major agreement8-K

The 5 newest of 87 articles that name the company.

Timeline
Kind of data

Timeline

Changes and notable records, by the date each became public

  1. 9 Oct 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  2. 9 Oct 2026Filings record

    Director or officer change

  3. 18 Sep 2026Filings record

    Delisting notice or listing transfer

  4. 6 Aug 2026Insiders record

    PICKER DONALD H (Chief Science Officer) bought 173,333 shares of MBRX (dated 5 Aug 2026)

  5. 6 Aug 2026Insiders record

    Foster Jonathan P. (Chief Financial Officer) bought 293,333 shares of MBRX (dated 5 Aug 2026)

  6. 6 Aug 2026Insiders record

    KLEMP WALTER V (CEO and President) bought 533,333 shares of MBRX (dated 5 Aug 2026)

  7. 30 Jul 2026Filings record

    Registered new securities for sale (S-1)

  8. 30 Jul 2026Filings record

    Registered new securities for sale (S-1)

  9. 29 Jul 2026Filings record

    Registered new securities for sale (S-1)

  10. 21 Nov 2025Filings record

    Delisting notice or listing transfer

  11. 13 Nov 2025Short interest and volume change

    had 8.7M shares sold short in the 31 Oct 2025 report, 71× the same report last year.

    Same report last year: 122K; its normal report is 853K.

    See the evidence
    This period
    8.7M (the 31 Oct 2025 report)
    Normal report (median of 24 earlier)
    853K
    Typical spread (median absolute deviation)
    809K
    How far from its usual level
    +6.6
    Same report last year
    122K
    History used
    2,863 days
    2024-10-31: 122K2024-11-15: 54K2024-11-29: 21K2024-12-13: 34K2024-12-31: 82K2025-01-15: 170K2025-01-31: 173K2025-02-14: 2.2M2025-02-28: 1.1M2025-03-14: 464K2025-03-31: 572K2025-04-15: 465K2025-04-30: 725K2025-05-15: 982K2025-05-30: 603K2025-06-13: 1.9M2025-06-30: 3.4M2025-07-15: 5.2M2025-07-31: 4.1M2025-08-15: 3.3M2025-08-29: 2.8M2025-09-15: 2.3M2025-09-30: 2.8M2025-10-15: 3.9M2025-10-31: 8.7M
    the 31 Oct 2025 report24 earlier reportsnormal: 853K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  12. 25 Oct 2025Short interest and volume change

    had 3.9M shares sold short in the 15 Oct 2025 report, 23× the same report last year.

    Same report last year: 172K; its normal report is 664K.

    See the evidence
    This period
    3.9M (the 15 Oct 2025 report)
    Normal report (median of 24 earlier)
    664K
    Typical spread (median absolute deviation)
    596K
    How far from its usual level
    +3.7
    Same report last year
    172K
    History used
    2,847 days
    2024-10-15: 172K2024-10-31: 122K2024-11-15: 54K2024-11-29: 21K2024-12-13: 34K2024-12-31: 82K2025-01-15: 170K2025-01-31: 173K2025-02-14: 2.2M2025-02-28: 1.1M2025-03-14: 464K2025-03-31: 572K2025-04-15: 465K2025-04-30: 725K2025-05-15: 982K2025-05-30: 603K2025-06-13: 1.9M2025-06-30: 3.4M2025-07-15: 5.2M2025-07-31: 4.1M2025-08-15: 3.3M2025-08-29: 2.8M2025-09-15: 2.3M2025-09-30: 2.8M2025-10-15: 3.9M
    the 15 Oct 2025 report24 earlier reportsnormal: 664K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  13. 11 Sep 2025Short interest and volume change

    had 2.8M shares sold short in the 29 Aug 2025 report, 26× the same report last year.

    Same report last year: 107K; its normal report is 464K.

    See the evidence
    This period
    2.8M (the 29 Aug 2025 report)
    Normal report (median of 24 earlier)
    464K
    Typical spread (median absolute deviation)
    370K
    How far from its usual level
    +4.2
    Same report last year
    107K
    History used
    2,800 days
    2024-08-30: 107K2024-09-13: 125K2024-09-30: 171K2024-10-15: 172K2024-10-31: 122K2024-11-15: 54K2024-11-29: 21K2024-12-13: 34K2024-12-31: 82K2025-01-15: 170K2025-01-31: 173K2025-02-14: 2.2M2025-02-28: 1.1M2025-03-14: 464K2025-03-31: 572K2025-04-15: 465K2025-04-30: 725K2025-05-15: 982K2025-05-30: 603K2025-06-13: 1.9M2025-06-30: 3.4M2025-07-15: 5.2M2025-07-31: 4.1M2025-08-15: 3.3M2025-08-29: 2.8M
    the 29 Aug 2025 report24 earlier reportsnormal: 464K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  14. 27 Aug 2025Short interest and volume change

    had 3.3M shares sold short in the 15 Aug 2025 report, 64× the same report last year.

    Same report last year: 51K; its normal report is 318K.

    See the evidence
    This period
    3.3M (the 15 Aug 2025 report)
    Normal report (median of 24 earlier)
    318K
    Typical spread (median absolute deviation)
    266K
    How far from its usual level
    +7.6
    Same report last year
    51K
    History used
    2,786 days
    2024-08-15: 51K2024-08-30: 107K2024-09-13: 125K2024-09-30: 171K2024-10-15: 172K2024-10-31: 122K2024-11-15: 54K2024-11-29: 21K2024-12-13: 34K2024-12-31: 82K2025-01-15: 170K2025-01-31: 173K2025-02-14: 2.2M2025-02-28: 1.1M2025-03-14: 464K2025-03-31: 572K2025-04-15: 465K2025-04-30: 725K2025-05-15: 982K2025-05-30: 603K2025-06-13: 1.9M2025-06-30: 3.4M2025-07-15: 5.2M2025-07-31: 4.1M2025-08-15: 3.3M
    the 15 Aug 2025 report24 earlier reportsnormal: 318K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  15. 12 Aug 2025Short interest and volume change

    had 4.1M shares sold short in the 31 Jul 2025 report, 145× the same report last year.

    Same report last year: 28K; its normal report is 172K.

    See the evidence
    This period
    4.1M (the 31 Jul 2025 report)
    Normal report (median of 24 earlier)
    172K
    Typical spread (median absolute deviation)
    148K
    How far from its usual level
    +17.7
    Same report last year
    28K
    History used
    2,771 days
    2024-07-31: 28K2024-08-15: 51K2024-08-30: 107K2024-09-13: 125K2024-09-30: 171K2024-10-15: 172K2024-10-31: 122K2024-11-15: 54K2024-11-29: 21K2024-12-13: 34K2024-12-31: 82K2025-01-15: 170K2025-01-31: 173K2025-02-14: 2.2M2025-02-28: 1.1M2025-03-14: 464K2025-03-31: 572K2025-04-15: 465K2025-04-30: 725K2025-05-15: 982K2025-05-30: 603K2025-06-13: 1.9M2025-06-30: 3.4M2025-07-15: 5.2M2025-07-31: 4.1M
    the 31 Jul 2025 report24 earlier reportsnormal: 172K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  16. 25 Jul 2025Short interest and volume change

    had 5.2M shares sold short in the 15 Jul 2025 report, 245× the same report last year.

    Same report last year: 21K; its normal report is 171K.

    See the evidence
    This period
    5.2M (the 15 Jul 2025 report)
    Normal report (median of 24 earlier)
    171K
    Typical spread (median absolute deviation)
    147K
    How far from its usual level
    +23.3
    Same report last year
    21K
    History used
    2,755 days
    2024-07-15: 21K2024-07-31: 28K2024-08-15: 51K2024-08-30: 107K2024-09-13: 125K2024-09-30: 171K2024-10-15: 172K2024-10-31: 122K2024-11-15: 54K2024-11-29: 21K2024-12-13: 34K2024-12-31: 82K2025-01-15: 170K2025-01-31: 173K2025-02-14: 2.2M2025-02-28: 1.1M2025-03-14: 464K2025-03-31: 572K2025-04-15: 465K2025-04-30: 725K2025-05-15: 982K2025-05-30: 603K2025-06-13: 1.9M2025-06-30: 3.4M2025-07-15: 5.2M
    the 15 Jul 2025 report24 earlier reportsnormal: 171K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  17. 27 Jun 2025Filings record

    Delisting notice or listing transfer

  18. 26 Jun 2025Short interest and volume change

    had 1.9M shares sold short in the 13 Jun 2025 report, 84× the same report last year.

    Same report last year: 23K; its normal report is 148K.

    See the evidence
    This period
    1.9M (the 13 Jun 2025 report)
    Normal report (median of 24 earlier)
    148K
    Typical spread (median absolute deviation)
    119K
    How far from its usual level
    +10.2
    Same report last year
    23K
    History used
    2,723 days
    2024-06-14: 23K2024-06-28: 30K2024-07-15: 21K2024-07-31: 28K2024-08-15: 51K2024-08-30: 107K2024-09-13: 125K2024-09-30: 171K2024-10-15: 172K2024-10-31: 122K2024-11-15: 54K2024-11-29: 21K2024-12-13: 34K2024-12-31: 82K2025-01-15: 170K2025-01-31: 173K2025-02-14: 2.2M2025-02-28: 1.1M2025-03-14: 464K2025-03-31: 572K2025-04-15: 465K2025-04-30: 725K2025-05-15: 982K2025-05-30: 603K2025-06-13: 1.9M
    the 13 Jun 2025 report24 earlier reportsnormal: 148K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  19. 24 Jun 2025Insiders record

    KLEMP WALTER V (CEO and President) bought 675,675 shares of MBRX ($250,000) (dated 23 Jun 2025)

  20. 24 Jun 2025Insiders record

    Foster Jonathan P. (Chief Financial Officer) bought 270,270 shares of MBRX ($100,000) (dated 23 Jun 2025)

  21. 16 Jun 2025Filings record

    Registered new securities for sale (S-1)

  22. 11 Jun 2025Filings record

    Registered new securities for sale (S-1)

  23. 6 Jun 2025Filings record

    Registered new securities for sale (S-1)

  24. 2 Jun 2025Filings record

    Registered new securities for sale (S-1)

  25. 28 May 2025Short interest and volume change

    had 982K shares sold short in the 15 May 2025 report, 29× the same report last year.

    Same report last year: 34K; its normal report is 115K.

    See the evidence
    This period
    982K (the 15 May 2025 report)
    Normal report (median of 24 earlier)
    115K
    Typical spread (median absolute deviation)
    83K
    How far from its usual level
    +7.1
    Same report last year
    34K
    History used
    2,694 days
    2024-05-15: 34K2024-05-31: 21K2024-06-14: 23K2024-06-28: 30K2024-07-15: 21K2024-07-31: 28K2024-08-15: 51K2024-08-30: 107K2024-09-13: 125K2024-09-30: 171K2024-10-15: 172K2024-10-31: 122K2024-11-15: 54K2024-11-29: 21K2024-12-13: 34K2024-12-31: 82K2025-01-15: 170K2025-01-31: 173K2025-02-14: 2.2M2025-02-28: 1.1M2025-03-14: 464K2025-03-31: 572K2025-04-15: 465K2025-04-30: 725K2025-05-15: 982K
    the 15 May 2025 report24 earlier reportsnormal: 115K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  26. 23 May 2025Filings record

    Delisting notice or listing transfer

  27. 10 May 2025Short interest and volume change

    had 725K shares sold short in the 30 Apr 2025 report, 23× the same report last year.

    Same report last year: 31K; its normal report is 95K.

    See the evidence
    This period
    725K (the 30 Apr 2025 report)
    Normal report (median of 24 earlier)
    95K
    Typical spread (median absolute deviation)
    72K
    How far from its usual level
    +5.9
    Same report last year
    31K
    History used
    2,679 days
    2024-04-30: 31K2024-05-15: 34K2024-05-31: 21K2024-06-14: 23K2024-06-28: 30K2024-07-15: 21K2024-07-31: 28K2024-08-15: 51K2024-08-30: 107K2024-09-13: 125K2024-09-30: 171K2024-10-15: 172K2024-10-31: 122K2024-11-15: 54K2024-11-29: 21K2024-12-13: 34K2024-12-31: 82K2025-01-15: 170K2025-01-31: 173K2025-02-14: 2.2M2025-02-28: 1.1M2025-03-14: 464K2025-03-31: 572K2025-04-15: 465K2025-04-30: 725K
    the 30 Apr 2025 report24 earlier reportsnormal: 95K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  28. 10 Apr 2025Short interest and volume change

    had 572K shares sold short in the 31 Mar 2025 report, 13× the same report last year.

    Same report last year: 45K; its normal report is 53K.

    See the evidence
    This period
    572K (the 31 Mar 2025 report)
    Normal report (median of 24 earlier)
    53K
    Typical spread (median absolute deviation)
    31K
    How far from its usual level
    +10.4
    Same report last year
    45K
    History used
    2,649 days
    2024-03-28: 45K2024-04-15: 27K2024-04-30: 31K2024-05-15: 34K2024-05-31: 21K2024-06-14: 23K2024-06-28: 30K2024-07-15: 21K2024-07-31: 28K2024-08-15: 51K2024-08-30: 107K2024-09-13: 125K2024-09-30: 171K2024-10-15: 172K2024-10-31: 122K2024-11-15: 54K2024-11-29: 21K2024-12-13: 34K2024-12-31: 82K2025-01-15: 170K2025-01-31: 173K2025-02-14: 2.2M2025-02-28: 1.1M2025-03-14: 464K2025-03-31: 572K
    the 31 Mar 2025 report24 earlier reportsnormal: 53K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  29. 31 Mar 2025Filings record

    Registered new securities for sale (S-1)

  30. 12 Mar 2025Short interest and volume change

    had 1.1M shares sold short in the 28 Feb 2025 report, 8.0× the same report last year.

    Same report last year: 134K; its normal report is 48K.

    See the evidence
    This period
    1.1M (the 28 Feb 2025 report)
    Normal report (median of 24 earlier)
    48K
    Typical spread (median absolute deviation)
    27K
    How far from its usual level
    +20.7
    Same report last year
    134K
    History used
    2,618 days
    2024-02-29: 134K2024-03-15: 31K2024-03-28: 45K2024-04-15: 27K2024-04-30: 31K2024-05-15: 34K2024-05-31: 21K2024-06-14: 23K2024-06-28: 30K2024-07-15: 21K2024-07-31: 28K2024-08-15: 51K2024-08-30: 107K2024-09-13: 125K2024-09-30: 171K2024-10-15: 172K2024-10-31: 122K2024-11-15: 54K2024-11-29: 21K2024-12-13: 34K2024-12-31: 82K2025-01-15: 170K2025-01-31: 173K2025-02-14: 2.2M2025-02-28: 1.1M
    the 28 Feb 2025 report24 earlier reportsnormal: 48K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  31. 27 Feb 2025Short interest and volume change

    had 2.2M shares sold short in the 14 Feb 2025 report, 16× the same report last year.

    Same report last year: 138K; its normal report is 48K.

    See the evidence
    This period
    2.2M (the 14 Feb 2025 report)
    Normal report (median of 24 earlier)
    48K
    Typical spread (median absolute deviation)
    27K
    How far from its usual level
    +43.0
    Same report last year
    138K
    History used
    2,604 days
    2024-02-15: 138K2024-02-29: 134K2024-03-15: 31K2024-03-28: 45K2024-04-15: 27K2024-04-30: 31K2024-05-15: 34K2024-05-31: 21K2024-06-14: 23K2024-06-28: 30K2024-07-15: 21K2024-07-31: 28K2024-08-15: 51K2024-08-30: 107K2024-09-13: 125K2024-09-30: 171K2024-10-15: 172K2024-10-31: 122K2024-11-15: 54K2024-11-29: 21K2024-12-13: 34K2024-12-31: 82K2025-01-15: 170K2025-01-31: 173K2025-02-14: 2.2M
    the 14 Feb 2025 report24 earlier reportsnormal: 48K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  32. 11 Feb 2025Filings record

    Registered new securities for sale (S-1)

  33. 10 Feb 2025Filings record

    Registered new securities for sale (S-1)

  34. 29 Jan 2025Filings record

    Registered new securities for sale (S-1)

  35. 13 Dec 2024Filings record

    Registered new securities for sale (S-1)

  36. 25 Oct 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  37. 25 Oct 2024Filings record

    Director or officer change

  38. 15 Aug 2024Filings record

    Registered new securities for sale (S-1)

  39. 15 Aug 2024Filings record

    Registered new securities for sale (S-1) (dated 14 Aug 2024)

  40. 30 Jul 2024Filings record

    Registered new securities for sale (S-1)

Showing the newest 40 of 110 entries; narrow the window or the kind of data to see older ones.

Not listed: 179 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001659617
Ticker
MBRX
Domain
moleculin.com
Hq location
TX|HOUSTON|77007 (1 unverified)
Name
Moleculin Biotech, Inc.
  • SEC Form 13F institutional holdings378 data points30 Jun 2016 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)241 records1 Feb 2016 to 16 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)592 data points27 Jul 2015 to 6 Nov 2026
  • SEC Form 4 insider transactions17 records, 44 data points26 Apr 2017 to 5 Aug 2026
  • FINRA short interest (twice monthly)624 data points29 Dec 2017 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)4144 data points1 Aug 2018 to 20 Nov 2026